Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

marijuana, opiates and PCP. By validating these drug classes in breath, Omega is advancing a testing option designed to help employers, courts, criminal justice programs, treatment and recovery organizations, schools, and other safety-sensitive...

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

and obesity makes this access moment particularly important for eligible Medicare beneficiaries. We are committed to helping patients, caregivers, and healthcare professionals navigate this program with confidence." The Medicare GLP-1 Bridge is...

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

bringing together mapping, intracardiac ultrasound, therapy technologies and clinical support solutions designed to help physicians navigate increasingly complex ablation procedures. Cardiovascular Solutions from Johnson & Johnson MedTech Across...

StatLab Introduces CytoPath Disc, Enhancing Global Standards in Cell Block Preparation

collaboration between our global R&D sites.” About StatLab Medical Products StatLab Medical Products has been dedicated to helping anatomic pathology laboratories provide the best possible patient care for 50 years. We offer a complete portfolio of...

FDA Grants Approval to TRYNGOLZA® (olezarsen) for the Treatment of Severe Hypertriglyceridemia, Marking a First-in-Class Milestone

need for continued innovation and improved care for patients living with this serious condition." Ionis is committed to helping people access the medicines they are prescribed and will offer a full suite of services for people prescribed TRYNGOLZA...

FDA Grants Approval to TRYNGOLZA® (olezarsen) for the Treatment of Severe Hypertriglyceridemia, Marking a First-in-Class Milestone

need for continued innovation and improved care for patients living with this serious condition." Ionis is committed to helping people access the medicines they are prescribed and will offer a full suite of services for people prescribed TRYNGOLZA...

Zeta Surgical® has announced the successful treatment of the first patient using its Zeta TMS Navigation System at HOPE Therapeutics.

advancements provide, and honored to offer this cutting-edge treatment to patients across our HOPE Therapeutics clinics, helping improve outcomes and quality of life." About ZETA SURGICAL ZETA SURGICAL is redefining the standard of care for...

Upsher-Smith Expands KYMBEE™ (Deflazacort) Family of Products with Launch of Oral Suspension for the Treatment of Duchenne Muscular Dystrophy

Italy), KYMBEE™ is the only deflazacort backed by the Company's comprehensive Promise of Support® Program, designed to help children living with Duchenne muscular dystrophy receive the treatment they need as easily, quickly and reliably as...

Strong Performance Across More Than 200 Customer Audits Highlighted by Piramal Pharma Solutions

transformation to support sustained compliance, continuous audit readiness, and operational effectiveness. This approach helps the Company proactively address evolving regulatory expectations while maintaining a high level of readiness across its...

CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Receives U.S. FDA Approval for an Additional Indication in Children and Adolescents Aged 2–17 Years at Increased Risk for Pneumococcal Disease

protection by including serotypes not contained in approved primary pediatric PCV series, and represents a new approach to helping protect children and adolescents at increased risk for pneumococcal disease.” The approval is based on data from the...

WISE Closes Oversubscribed €30 Million Series D Financing Round with ENEA Tech and Biomedical Joining as Strategic Investor

of WISE. “Welcoming ENEA Tech and Biomedical on board is a testament to the strength of what WISE has built. I am proud to help the company scale its technology and bring high-impact solutions to patients with neurological conditions and chronic...

Rugiet Launched Physician-Prescribed Peptide and Longevity Therapies, Setting a New Standard in Performance Medicine

Rugiet, the performance medicine company that’s helped more than 500,000 men take control of their health, announced the expansion of its treatment areas to include longevity. Rugiet is bringing its physician-prescribed standards to an emerging...

Bayer’s AMBELVIST® (gadoquatrane) Gains FDA Approval for Contrast-Enhanced MRI in Detection of Lesions with Abnormal Vascularity Across CNS and Non-CNS Body Regions

Cities and an investigator for the QUANTI clinical studies. “With this approval, we now have an additional option that can help deliver contrast-enhanced images at the lowest macrocyclic GBCA dose, reducing gadolinium exposure while preserving the...

Leading Dermatologist Dr. Dendy Engelman Joins ELASTEN® to Advance the Future of Science-Backed Skin Health from Within

FASDS, FAAD. As ELASTEN®'s official dermatology expert, Dr. Engelman will serve as a key educational voice for the brand, helping consumers, media, and healthcare professionals better understand the science of collagen supplementation and its role...

Breast Milk–Inspired Synbiotic for Infant Gut Health Developed Through Partnership Between NurtureBio and Lallemand

found in human breast milk, such as HMOs, in shaping that ecosystem. NurtureBio's first synbiotic product is formulated to help bridge this gap by combining HMOs with specific probiotic strains, including Bifidobacterium infantis Rosell®–33 and...

IMAAVY® (nipocalimab-aahu) demonstrated rapid onset and durable hemoglobin response in a pivotal Phase 2/3 study of warm autoimmune hemolytic anemia (wAIHA), a disease with no FDA-approved therapies

Italy.g "Achieving hemoglobin improvements this quickly and at this scale is important in clinical practice, as it could help improve the debilitating fatigue that people living with warm autoimmune hemolytic anemia experience." Key findings from...

Exilby®, a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain, Receives Its First European Marketing Authorization from VERTANICAL; Pivotal U.S. Phase 3 Trial Underway

point in chronic pain treatment. As healthcare systems worldwide seek effective non-opioid approaches, Exilby® may help open the door to a new treatment paradigm for patients living with chronic pain. About Exilby® Exilby® is an investigational...

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

long-term care patients receiving ZUNVEYL. While the study was not designed to establish causality, these findings may help inform clinical discussions and future research in this challenging patient population.” Because BEACON was a retrospective...

Growing Demand for Digital Pharmacy Underscores TelyRx Surpassing 1 Million Prescriptions

that provides access to more than 450 FDA-approved medications. Through a fully integrated online experience, TelyRx helps patients access treatment for more than 60 acute and chronic health conditions, including allergies, asthma, diabetes, sexual...

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

by Elle, Forbes, and Cosmopolitan as the "OG of the Clean Beauty Movement," and recipient of Glamour's Top Eco-Leader, she helped shape the organic and clean skincare industry long before it became mainstream. Karen was a founding member and served...